Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 5, Issue 179, Pages 179ra44-179ra44
Publisher
American Association for the Advancement of Science (AAAS)
Online
2013-04-04
DOI
10.1126/scitranslmed.3005213
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of [(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): A Dual Orexin Receptor Antagonist with Potent Sleep-Promoting Properties
- (2012) Paul J. Coleman et al. ChemMedChem
- Differential Effects of a Dual Orexin Receptor Antagonist (SB-649868) and Zolpidem on Sleep Initiation and Consolidation, SWS, REM Sleep and EEG Power Spectra in a Model of Situational Insomnia
- (2012) Paolo Bettica et al. NEUROPSYCHOPHARMACOLOGY
- Orexin Receptors: Pharmacology and Therapeutic Opportunities
- (2011) Thomas E. Scammell et al. Annual Review of Pharmacology and Toxicology
- Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist
- (2011) Christopher J. Winrow et al. JOURNAL OF NEUROGENETICS
- Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist
- (2011) Paolo Bettica et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Sleep Neurobiology from a Clinical Perspective
- (2011) SLEEP
- Orexin Receptor Antagonism, a New Sleep-Promoting Paradigm: An Ascending Single-Dose Study With Almorexant
- (2010) P Hoever et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
- (2010) Hendrik Dietrich et al. PSYCHOPHARMACOLOGY
- Discovery of a Potent, CNS-Penetrant Orexin Receptor Antagonist Based on anN,N-Disubstituted-1,4-diazepane Scaffold that Promotes Sleep in Rats
- (2009) David B. Whitman et al. ChemMedChem
- Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem
- (2009) TIM R. M. LEUFKENS et al. JOURNAL OF SLEEP RESEARCH
- Systemic and intrabasalis administration of the orexin-1 receptor antagonist, SB-334867, disrupts attentional performance in rats
- (2009) Karen E. Boschen et al. PSYCHOPHARMACOLOGY
- The α1 subunit of the GABA(A) receptor modulates fear learning and plasticity in the lateral amygdala
- (2009) Brian Wiltgen Frontiers in Behavioral Neuroscience
- Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
- (2008) S. Otmani et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- International Union of Pharmacology. LXX. Subtypes of -Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update
- (2008) R. W. Olsen et al. PHARMACOLOGICAL REVIEWS
- The effect of antagonization of orexin 1 receptors in CA1 and dentate gyrus regions on memory processing in passive avoidance task
- (2007) Esmaeil Akbari et al. BEHAVIOURAL BRAIN RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started